- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05729685
Aerobic Adaptations With Various Training Methods
Aerobic Adaptations Following Two Iso-effort Training Programs: An Intense Continuous and a High-intensity Interval
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim of this study was to compare the adaptations after a 6-week training period between the intense continuous and the high-intensity interval training methods performed under iso-effort conditions on maximal (VO2max and PTV) and submaximal (critical velocity, lactate threshold parameters and running economy) aerobic performance parameters.
A parallel group research design was used in the present study. Initially, 26 participants (10 males and 16 females), using stratified randomization (gender was the variable of stratification) were randomly assigned (1:1), according to a random-number table, either to an intense continuous training group (CON) or to a high-intensity interval training group (INT).
The INT group trained using the interval method. During the exercise sessions the participants ran each bout at an intensity corresponding to 90% of PTV. PTV was used to prescribe the exercise intensity at the INT group. The duration of the running-bouts was equal to ¼ of the individual time to exhaustion at 90% of PTV (determined during the CV testing) followed by passive rest equal to 2/3 of exercise duration. The duration of the exercise-bouts was individualized based on the time to exhaustion at 90% of PTV to reduce the between subject's variability. The participants terminated each exercise session when an RPE value of 17 was reached. Running bout duration and intensity were adjusted after 7 training sessions (during the 3rd week) following a reassessment of the time to exhaustion at 90% of the "new" PTV achieved during mid-testing as a result of training.
The CONT group trained using the continuous method. During the training sessions the participants ran with an intensity corresponding to -2,5% of CV until they reported a rating of 17 at the 6-20 Borg's scale. Running velocity was adjusted after 7 training sessions (during the 3rd week) after reassessment of CV. CV was used to determine the exercise intensity in the CONT group to ensure that all individuals would ran at the heavy intensity domain and be able to complete at least 15 min of continuous running, and to minimize the high inter-individual variations in endurance time at intensities near the upper limit of the heavy intensity domain. Using PTV to determine the intensity in the CONT group, would increase the possibility for trainees to exercise at different exercise intensity domains.
During the experiment, participants will not perform any other form of training besides of that applied in the current study. VO2max, PTV, oxygen consumptions, heart rates and the velocities corresponding to the 1st and the 2nd lactate thresholds (LT1 and LT2), the velocity at 4 mmol/L of blood lactate concentration (v4mmol), running economy, and critical velocity (CV) will be measured before, after 7 training sessions (3rd week, two days after the 7th training session), and after the completion of training program.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Rodopi
-
Komotini, Rodopi, Greece, 69100
- Department of Physical Education and Sport Science
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria
- All participants should have been involved in low intensity continuous training,
- All participants should have been training 1-3 times per week for 30-45 min for at least three months.
Exclusion criteria
- Not familiar with aerobic training
- Any health issues that did not allow participation in regular exercise training.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Interval training
The interval group trained using the interval trainining method.
|
The interval training group trained using the interval method.
During the exercise sessions the participants ran each bout at an intensity corresponding to 90% of PTV.
PTV was used to prescribe the exercise intensity at the INT group.
The duration of the running-bouts was equal to ¼ of the individual time to exhaustion at 90% of PTV (determined during the CV testing) followed by passive rest equal to 2/3 of exercise duration.
The duration of the exercise-bouts was individualized based on the time to exhaustion at 90% of PTV to reduce the between subject's variability.
The participants terminated each exercise session when an RPE value of 17 was reached.
Running bout duration and intensity were adjusted after 7 training sessions (during the 3rd week) following a reassessment of the time to exhaustion at 90% of the "new" PTV achieved during mid-testing as a result of training.
|
|
Experimental: Continuous training
The continuous group trained using the continuous training method.
|
The continuous group trained using the continuous method.
During the training sessions the participants ran with an intensity corresponding to -2,5% of CV until they reported a rating of 17 at the 6-20 Borg's scale.
Running velocity was adjusted after 7 training sessions (during the 3rd week) after reassessment of CV.
CV was used to determine the exercise intensity in the CONT group to ensure that all individuals would ran at the heavy intensity domain and be able to complete at least 15 min of continuous running, and to minimize the high inter-individual variations in endurance time at intensities near the upper limit of the heavy intensity domain.
Using PTV to determine the intensity in the CONT group, would increase the possibility for trainees to exercise at different exercise intensity domains.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in maximal oxygen consumption
Time Frame: At the beginning of the training program, the 3rd week of training (after 7 training sessions), and the 7th week after the start of the intervention (after the completion of 6 weeks of training, 14 training sessions)
|
Maximal oxygen consumption in ml/kg/min
|
At the beginning of the training program, the 3rd week of training (after 7 training sessions), and the 7th week after the start of the intervention (after the completion of 6 weeks of training, 14 training sessions)
|
|
Changes in peak treadmill velocity
Time Frame: At the beginning of the training program, the 3rd week of training (after 7 training sessions), and the 7th week after the start of the intervention (after the completion of 6 weeks of training, 14 training sessions)
|
Peak treadmill velocity using a maximal incremental test to exhaustion on a treadmill in km/h
|
At the beginning of the training program, the 3rd week of training (after 7 training sessions), and the 7th week after the start of the intervention (after the completion of 6 weeks of training, 14 training sessions)
|
|
Changes in running velocities at the 1st and the 2nd lactate thresholds
Time Frame: At the beginning of the training program, the 3rd week of training (after 7 training sessions), and the 7th week after the start of the intervention (after the completion of 6 weeks of training, 14 training sessions)
|
Running velocities (km/h) at the 1st and the 2nd lactate thresholds by measuring the changes in blood lactate concentration during a maximal incremental test to exhaustion on a treadmill.
|
At the beginning of the training program, the 3rd week of training (after 7 training sessions), and the 7th week after the start of the intervention (after the completion of 6 weeks of training, 14 training sessions)
|
|
Changes in critical velocity
Time Frame: At the beginning of the training program, the 3rd week of training (after 7 training sessions), and the 7th week after the start of the intervention (after the completion of 6 weeks of training, 14 training sessions)
|
Critical velocity (km/h) determined by having the participants ran until exhaustion at velocities corresponding to 90, 100, and 110% of peak treadmill velocity.
Using linear regression analyses, the relationship between the distance covered at each run and the time to exhaustion was calculated.
Τhe slope of the linear regression line was the critical velocity.
|
At the beginning of the training program, the 3rd week of training (after 7 training sessions), and the 7th week after the start of the intervention (after the completion of 6 weeks of training, 14 training sessions)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in running economy
Time Frame: At the beginning of the training program and the 7th week after the start of the intervention (after the completion of 6 weeks of training, 14 training sessions)
|
Running economy determined by measuring the oxygen consumption (ml/kg/min) while running for 10 min at a velocity corresponding to 70% of the pre-training peak treadmill velocity
|
At the beginning of the training program and the 7th week after the start of the intervention (after the completion of 6 weeks of training, 14 training sessions)
|
|
Changes in running velocity at a blood lactate concentration of 4 mmol/L
Time Frame: At the beginning of the training program and the 7th week after the start of the intervention (after the completion of 6 weeks of training, 14 training sessions)
|
Running velocity (km/h) at a blood lactate concentration of 4 mmol/L determined by the individual relationship between lactate concentrations and running velocities during an incremental test by applying a nonlinear regression model.
|
At the beginning of the training program and the 7th week after the start of the intervention (after the completion of 6 weeks of training, 14 training sessions)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- AERCONINT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
RAGE BioRecruitingHealthy | Healthy SmokerAustralia
Clinical Trials on Interval training
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
University Hospital, MontpellierRecruiting
-
Norwegian University of Science and TechnologyAarhus University HospitalCompleted
-
St. Olavs HospitalNorwegian University of Science and TechnologyCompletedTachycardia, Ventricular | Defibrillators, ImplantableNorway
-
Riphah International UniversityCompletedMyocardial InfarctionPakistan
-
Kuopio Research Institute of Exercise MedicineKuopio University Hospital; University of Basel; University of Eastern Finland; Social Insurance Institution, FinlandTerminatedUnstable Angina Pectoris | Acute Myocardial Infarction | Recurrent Myocardial InfarctionFinland
-
Cairo UniversityKasr El Aini HospitalCompletedDiabetes Mellitus, Type 2Egypt
-
Universidad Santo TomasCompletedMetabolic DiseasesColombia
-
Norwegian University of Science and TechnologyCompletedObesity | OverweightNorway
-
Universidad SurcolombianaMaciste Macias; Gilberto AstaizaRecruiting